Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER_GOV × Curcumin × Clear all

Phase

Phase 3 2 Phase NA 1 Phase 2 1

Status

Sponsor Class

OTHER 21 OTHER_GOV 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1

Interventions

Capecitabine 24 Cisplatin 21 tislelizumab 20 apatinib 20 Gemcitabine 20 Oxaliplatin 19 Paclitaxel 18 Irinotecan 17 Carboplatin 16 Docetaxel 15 Bevacizumab 13 Fluorouracil 12 Drug Therapy 11 pembrolizumab 10 camrelizumab 10 Cyclophosphamide 10 Radiation 9 Vinorelbine 8 S 1 (combination) 8 Rituximab 7 Erlotinib Hydrochloride 7 Cetuximab 7 Leucovorin 6 Albumin-Bound Paclitaxel 6 toripalimab 5 pyrotinib 5 fludarabine 5 Nivolumab 5 Injections 5 Everolimus 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04294836 2022-12-07

Curcumin in Advanced Cervical Cancer

Instituto Nacional de Cancerologia, Columbia

Phase 2 Withdrawn

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡